Commentary: Adenosine A2A Receptor Blockade Prevents Rotenone-Induced Motor Impairment in a Rat Model of Parkinsonism

Commentary: Adenosine A2A Receptor Blockade Prevents Rotenone-Induced Motor Impairment in a Rat Model of Parkinsonism

Bibliographic Details
Main Authors:	Marina F. de Souza, José M. M. Bispo, Pollyana C. Leal, Auderlan M. de Gois, José R. dos Santos
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2017-05-01
Series:	Frontiers in Behavioral Neuroscience
Subjects:	Parkinson disease adenosine neuroprotection caffeine dopamine
Online Access:	http://journal.frontiersin.org/article/10.3389/fnbeh.2017.00093/full

Similar Items

Neuroprotective effects of nanogold-based Ayurveda medicine Suvarna Bhasma against rotenone-induced Parkinson's-like model
by: Snehasis Biswas, et al.
Published: (2024-01-01)

Caffeine and Selective Adenosine Receptor Antagonists as New Therapeutic Tools for the Motivational Symptoms of Depression
by: Laura López-Cruz, et al.
Published: (2018-06-01)

Comparative Molecular Docking Studies of Selected Phytoconstituents on Adenosine A2A Receptor (PDB ID: 3UZA) as Potential Anti-Parkinson’s Agents
by: Namrata Kumari, et al.
Published: (2023-11-01)

The association of gene polymorphisms of adenosine and dopamine receptors with the response to caffeine citrate treatment in infants with apnea of prematurity: a prospective nested case-control study
by: Jiangbiao Xie, et al.
Published: (2024-10-01)

Impact of Caffeine Consumption on Type 2 Diabetes-Induced Spatial Memory Impairment and Neurochemical Alterations in the Hippocampus
by: João M. N. Duarte, et al.
Published: (2019-01-01)

Exposure to varenicline protects against locomotor alteration in a MPTP mouse model of Parkinson's disease
by: A. Ribeiro-Carvalho, et al.
Published: (2021-12-01)

Effects of Adenosine on the Sleep-Wake Cycle
by: Meriç Demeli, et al.
Published: (2022-09-01)

A highly reproducible rotenone model of Parkinson's disease
by: Jason R. Cannon, et al.
Published: (2009-05-01)

How can caffeine alleviate the motor symptoms of Parkinson’s disease? – the implications of adenosine 2A receptor antagonism
by: Anna Wójcik, et al.
Published: (2024-05-01)

Effects of caffeine on the detection of ischemia in patients undergoing adenosine stress cardiovascular magnetic resonance imaging
by: Simon Greulich, et al.
Published: (2017-12-01)

Blockade of adenosine A2A receptors prevents staurosporine-induced apoptosis of rat hippocampal neurons
by: Carla G. Silva, et al.
Published: (2007-08-01)

Testosterone propionate improves motor alterations and dopaminergic damage in the reserpine-induced progressive model of Parkinson's disease
by: José M.M. Bispo, et al.
Published: (2022-09-01)

Caffeine Protects Dopaminergic Neurons From Dopamine-Induced Neurodegeneration via Synergistic Adenosine-Dopamine D2-Like Receptor Interactions in Transgenic Caenorhabditis elegans
by: Rafael V. M. Manalo, et al.
Published: (2018-03-01)

Effects of Chronic Caffeine Consumption on Synaptic Function, Metabolism and Adenosine Modulation in Different Brain Areas
by: Cátia R. Lopes, et al.
Published: (2023-01-01)

The Role of the Adenosine System on Emotional and Cognitive Disturbances Induced by Ethanol Binge Drinking in the Immature Brain and the Beneficial Effects of Caffeine
by: Bruno Gonçalves Pinheiro, et al.
Published: (2022-10-01)

Antioxidant, anti-inflammatory and neuroprotective effect of kaempferol on rotenone-induced Parkinson’s disease model of rats and SH-S5Y5 cells by preventing loss of tyrosine hydroxylase
by: Xiaohua Pan, et al.
Published: (2020-11-01)

Influence of caffeine on blood pressure and platelet aggregation
by: José Wilson S. Cavalcante, et al.
Published: (2000-08-01)

Olfactory impairment is related to REM sleep deprivation in rotenone model of Parkinson's disease
by: Mariana F. Aurich, et al.

Adenosine kinase inhibition protects against cranial radiation-induced cognitive dysfunction
by: Munjal M Acharya, et al.
Published: (2016-06-01)

Ethanol and Caffeine effects on social interaction and recognition in mice: Involvement of adenosine A2A and A1 receptors
by: Laura López-Cruz, et al.
Published: (2016-11-01)

Antioxidant and Neuroprotective Effects of Caffeine against Alzheimer’s and Parkinson’s Disease: Insight into the Role of Nrf-2 and A2AR Signaling
by: Muhammad Ikram, et al.
Published: (2020-09-01)

Identification of minimum essential therapeutic mixtures from cannabis plant extracts by screening in cell and animal models of Parkinson’s disease
by: Michael G. Morash, et al.
Published: (2022-10-01)

Essential Control of the Function of the Striatopallidal Neuron by Pre-coupled Complexes of Adenosine A2A-Dopamine D2 Receptor Heterotetramers and Adenylyl Cyclase
by: Sergi Ferré, et al.
Published: (2018-04-01)

Adenosine A2A Receptors as Biomarkers of Brain Diseases
by: Ana Moreira-de-Sá, et al.
Published: (2021-07-01)

Rotenone Neurotoxicity Causes Dopamine Neuron Loss in Zebrafish
by: Simon Martel, et al.
Published: (2015-11-01)

Neuroprotective Efficacy of a Nanomicellar Complex of Carnosine and Lipoic Acid in a Rat Model of Rotenone-Induced Parkinson’s Disease
by: Olga Kulikova, et al.
Published: (2023-06-01)

The effect of low dose amphetamine in rotenone-induced toxicity in a mice model of Parkinson’s disease
by: Omar M.E. Abdel-Salam, et al.
Published: (2020-09-01)

Effects of nicotine analogs in an experimental model of Parkinson´s disease: role of CDK5 on dopamine release
by: George E. Barreto
Published: (2015-05-01)

Low Levels of Adenosine and GDNF Are Potential Risk Factors for Parkinson’s Disease with Sleep Disorders
by: Li Wang, et al.
Published: (2023-01-01)

Lifespan extension induced by caffeine in Caenorhabditis elegans is partially dependent on adenosine signaling
by: Jessika Cristina Bridi, et al.
Published: (2015-12-01)

Targets to Search for New Pharmacological Treatment in Idiopathic Parkinson’s Disease According to the Single-Neuron Degeneration Model
by: Sandro Huenchuguala, et al.
Published: (2024-06-01)

Dopamine D2 receptor dysfunction is rescued by adenosine A2A receptor antagonism in a model of DYT1 dystonia
by: Francesco Napolitano, et al.
Published: (2010-06-01)

Sudden Caffeine Withdrawal Triggers Migraine—A Randomized Controlled Trial
by: Karl B. Alstadhaug, et al.
Published: (2020-09-01)

The Role of Adenosine Receptors in Psychostimulant Addiction
by: Inmaculada Ballesteros-Yáñez, et al.
Published: (2018-01-01)

The Adenosinergic Signaling: A Complex but Promising Therapeutic Target for Alzheimer’s Disease
by: Lucrezia Cellai, et al.
Published: (2018-08-01)

Bone Marrow Mesenchymal Stem Cells' Secretome Exerts Neuroprotective Effects in a Parkinson's Disease Rat Model
by: Bárbara Mendes-Pinheiro, et al.
Published: (2019-11-01)

Caffeine and Parkinson’s Disease: Multiple Benefits and Emerging Mechanisms
by: Xiangpeng Ren, et al.
Published: (2020-12-01)

Caffeine intake interacts with Asian gene variants in Parkinson's disease: a study in 4488 subjectsResearch in context
by: Yi-Lin Ong, et al.
Published: (2023-11-01)

Absence of a synergic nigral proapoptotic effect triggered by REM sleep deprivation in the rotenone model of Parkinson´s disease
by: Luana C Kmita, et al.
Published: (2019-09-01)

Targeting Adenosine Signaling in Parkinson's Disease: From Pharmacological to Non-pharmacological Approaches
by: Luiza R. Nazario, et al.
Published: (2017-11-01)